Pamela received her B.S. in Biology from Mount Mercy University and her Ph.D. in Neuroscience from the University of Iowa. For her doctoral research, she investigated the molecular mechanisms by which the MED12 protein mediates vulnerability to schizophrenia. Prior to her employment at the NIH, Pamela was a consultant for Discovery Logic, a Thomson Reuters Company as a business data analyst in Custom Analytics and Engineered Solutions in Rockville, MD. Alongside the efforts provided to Thomson Reuters, she was also a freelance medicine and life sciences editor for Cactus Communications, Inc.
Last Modified January 14, 2013